Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 4
2003 12
2004 8
2005 6
2006 7
2007 15
2008 12
2009 15
2010 16
2011 17
2012 17
2013 23
2014 25
2015 33
2016 39
2017 39
2018 31
2019 22
2020 28
2021 35
2022 32
2023 39
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

433 results

Results by year

Filters applied: . Clear all
Page 1
Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection.
Phetsouphanh C, Jacka B, Ballouz S, Jackson KJL, Wilson DB, Manandhar B, Klemm V, Tan HX, Wheatley A, Aggarwal A, Akerman A, Milogiannakis V, Starr M, Cunningham P, Turville SG, Kent SJ, Byrne A, Brew BJ, Darley DR, Dore GJ, Kelleher AD, Matthews GV. Phetsouphanh C, et al. Among authors: dore gj. Nat Commun. 2024 Apr 17;15(1):3315. doi: 10.1038/s41467-024-47720-8. Nat Commun. 2024. PMID: 38632311 Free PMC article.
Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs: The ETHOS engage study.
Valerio H, Marshall AD, Conway A, Treloar C, Carter L, Martinello M, Henderson C, Amin J, Read P, Silk D, Degenhardt L, Prain B, Alavi M, Dore GJ, Grebely J; ETHOS Engage Study Group. Valerio H, et al. Among authors: dore gj. Int J Drug Policy. 2024 Apr 11;127:104394. doi: 10.1016/j.drugpo.2024.104394. Online ahead of print. Int J Drug Policy. 2024. PMID: 38608357
96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial.
Farrell M, Shahbazi J, Chambers M, Byrne M, Gholami J, Zahra E, Grebely J, Lintzeris N, Larance B, Ali R, Nielsen S, Dunlop A, Dore GJ, McDonough M, Montebello M, Weiss R, Rodgers C, Cook J, Degenhardt L; CoLAB study team. Farrell M, et al. Among authors: dore gj. Int J Drug Policy. 2024 Mar 23;127:104390. doi: 10.1016/j.drugpo.2024.104390. Online ahead of print. Int J Drug Policy. 2024. PMID: 38522175 Free article.
Vaccination coverage among people who inject drugs: A systematic review.
Price O, Swanton R, Grebely J, Hajarizadeh B, Webb P, Peacock A, Dore GJ, Cowie BC, Vickerman P, Degenhardt L. Price O, et al. Among authors: dore gj. Int J Drug Policy. 2024 Mar 18;127:104382. doi: 10.1016/j.drugpo.2024.104382. Online ahead of print. Int J Drug Policy. 2024. PMID: 38503233 Free article. Review.
Corrigendum to "Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales" [JHEP Reports 4 (2022)].
Bin Usman Shah SH, Alavi M, Hajarizadeh B, Matthews GV, Martinello M, Danta M, Amin J, Law MG, George J, Valerio H, Dore GJ. Bin Usman Shah SH, et al. Among authors: dore gj. JHEP Rep. 2024 Feb 15;6(3):101022. doi: 10.1016/j.jhepr.2024.101022. eCollection 2024 Mar. JHEP Rep. 2024. PMID: 38481634 Free PMC article.
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions.
Marshall AD, Willing AR, Kairouz A, Cunningham EB, Wheeler A, O'Brien N, Perera V, Ward JW, Hiebert L, Degenhardt L, Hajarizadeh B, Colledge S, Hickman M, Jawad D, Lazarus JV, Matthews GV, Scheibe A, Vickerman P, Dore GJ, Grebely J; Global HCV and HIV Treatment Restrictions Group. Marshall AD, et al. Among authors: dore gj. Lancet Gastroenterol Hepatol. 2024 Apr;9(4):366-382. doi: 10.1016/S2468-1253(23)00335-7. Epub 2024 Feb 15. Lancet Gastroenterol Hepatol. 2024. PMID: 38367631 Review.
Scale-up of Direct-Acting Antiviral Treatment in Prisons Is Both Cost-effective and Key to Hepatitis C Virus Elimination.
Shih STF, Stone J, Martin NK, Hajarizadeh B, Cunningham EB, Kwon JA, McGrath C, Grant L, Grebely J, Dore GJ, Lloyd AR, Vickerman P, Chambers GM. Shih STF, et al. Among authors: dore gj. Open Forum Infect Dis. 2023 Dec 18;11(2):ofad637. doi: 10.1093/ofid/ofad637. eCollection 2024 Feb. Open Forum Infect Dis. 2023. PMID: 38344130 Free PMC article.
433 results